• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.简单炎症生物标志物在重症新型冠状病毒肺炎患者中的预后作用:一项观察性研究
Hippokratia. 2022 Apr-Jun;26(2):70-77.
2
Predicting the Outcome of Patients with Severe COVID-19 with Simple Inflammatory Biomarkers: The Utility of Novel Combined Scores-Results from a European Tertiary/Referral Centre.用简单炎症生物标志物预测重症 COVID-19 患者的预后:新型综合评分的效用——来自欧洲三级/转诊中心的结果
J Clin Med. 2024 Feb 8;13(4):967. doi: 10.3390/jcm13040967.
3
[Value of modified ROX index in predicting the outcome of patients with acute respiratory distress syndrome due to SARS-CoV-2 infection treated with high-flow nasal cannula oxygen therapy].[改良ROX指数对预测新型冠状病毒2型感染所致急性呼吸窘迫综合征患者接受高流量鼻导管吸氧治疗预后的价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jun;36(6):585-590. doi: 10.3760/cma.j.cn121430-20240228-00171.
4
[Effect of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy on the clinical efficacy of coronavirus disease 2019 patients with acute respiratory distress syndrome].无创正压通气和高流量鼻导管氧疗对2019冠状病毒病急性呼吸窘迫综合征患者临床疗效的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jun;33(6):708-713. doi: 10.3760/cma.j.cn121430-20210104-00002.
5
High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?高流量鼻导管氧疗在 COVID-19 相关急性呼吸窘迫综合征中的应用:一种避免气管插管的安全方法?
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211019555. doi: 10.1177/17534666211019555.
6
Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis.高流量鼻导管与常规氧疗在 COVID-19 患者中的比较:系统评价和荟萃分析。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666231225323. doi: 10.1177/17534666231225323.
7
[Predictive value of neutrophil to lymphocyte ratio on 28-day mortality of patients with severe pneumonia].中性粒细胞与淋巴细胞比值对重症肺炎患者28天死亡率的预测价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Jul;31(7):827-831. doi: 10.3760/cma.j.issn.2095-4352.2019.07.006.
8
The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia.高流量鼻导管氧疗治疗新型冠状病毒肺炎的价值。
Eur J Clin Invest. 2021 Mar;51(3):e13435. doi: 10.1111/eci.13435. Epub 2020 Oct 31.
9
[Application effect and influencing factors of early awake prone position in patients with mild-to-moderate acute respiratory distress syndrome].[早期清醒俯卧位在轻至中度急性呼吸窘迫综合征患者中的应用效果及影响因素]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Jul;36(7):699-704. doi: 10.3760/cma.j.cn121430-20230925-00817.
10
Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19.入院时铁蛋白水平升高可预测新冠肺炎患者在重症监护病房的死亡率。
Med Clin (Engl Ed). 2021 Apr 9;156(7):324-331. doi: 10.1016/j.medcle.2020.11.015. Epub 2021 Apr 1.

引用本文的文献

1
Normalization of eosinophil count is predictive of oxygen weaning over the course of COVID-19 infection among hospitalized adults during the first wave of 2020 pandemic.在 2020 年大流行的第一波疫情期间,住院成人 COVID-19 感染过程中,嗜酸性粒细胞计数的正常化可预测氧脱机。
Front Immunol. 2024 May 24;15:1381059. doi: 10.3389/fimmu.2024.1381059. eCollection 2024.
2
Predicting the Outcome of Patients with Severe COVID-19 with Simple Inflammatory Biomarkers: The Utility of Novel Combined Scores-Results from a European Tertiary/Referral Centre.用简单炎症生物标志物预测重症 COVID-19 患者的预后:新型综合评分的效用——来自欧洲三级/转诊中心的结果
J Clin Med. 2024 Feb 8;13(4):967. doi: 10.3390/jcm13040967.

本文引用的文献

1
Non-Typical Clinical Presentation of COVID-19 Patients in Association with Disease Severity and Length of Hospital Stay.新型冠状病毒肺炎患者的非典型临床表现与疾病严重程度及住院时间的关系
J Pers Med. 2023 Jan 10;13(1):132. doi: 10.3390/jpm13010132.
2
The Impact of Comorbidities and Obesity on the Severity and Outcome of COVID-19 in Hospitalized Patients-A Retrospective Study in a Hungarian Hospital.合并症和肥胖对住院 COVID-19 患者严重程度和结局的影响——匈牙利医院的回顾性研究。
Int J Environ Res Public Health. 2023 Jan 12;20(2):1372. doi: 10.3390/ijerph20021372.
3
Novel Systemic Inflammation Markers to Predict COVID-19 Prognosis.新型全身性炎症标志物预测 COVID-19 预后。
Front Immunol. 2021 Oct 22;12:741061. doi: 10.3389/fimmu.2021.741061. eCollection 2021.
4
PaO/FiO ratio forecasts COVID-19 patients' outcome regardless of age: a cross-sectional, monocentric study.无论年龄如何,氧合指数均可预测新冠患者的预后:一项横断面单中心研究
Intern Emerg Med. 2022 Apr;17(3):665-673. doi: 10.1007/s11739-021-02840-7. Epub 2021 Oct 12.
5
The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia.C反应蛋白与淋巴细胞比值在预测新型冠状病毒肺炎严重程度中的价值
Arch Bronconeumol. 2021 Jan;57:79-82. doi: 10.1016/j.arbres.2020.07.038. Epub 2020 Sep 6.
6
Role of NLR, PLR, ELR and CLR in differentiating COVID-19 patients with and without pneumonia.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、嗜中性粒细胞与淋巴细胞比值和嗜酸性粒细胞与淋巴细胞比值在鉴别新冠肺炎患者是否合并肺炎中的作用。
Int J Clin Pract. 2021 Nov;75(11):e14781. doi: 10.1111/ijcp.14781. Epub 2021 Sep 12.
7
Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections.更新:C 反应蛋白在 COVID-19 及其他病毒感染中的研究进展。
Front Immunol. 2021 Aug 10;12:720363. doi: 10.3389/fimmu.2021.720363. eCollection 2021.
8
Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19.基于血常规的比值作为 COVID-19 患者 ICU 收治的预后标志物。
BMC Emerg Med. 2021 Jul 27;21(1):89. doi: 10.1186/s12873-021-00480-w.
9
Can Hematological Ratios Predict Outcome of COVID-19 Patients? A Multicentric Study.血液学指标能否预测COVID-19患者的预后?一项多中心研究。
J Blood Med. 2021 Jun 29;12:505-515. doi: 10.2147/JBM.S316681. eCollection 2021.
10
Hemogram as marker of in-hospital mortality in COVID-19.血常规作为 COVID-19 院内死亡率的标志物。
J Investig Med. 2021 Jun;69(5):962-969. doi: 10.1136/jim-2021-001810. Epub 2021 Apr 13.

简单炎症生物标志物在重症新型冠状病毒肺炎患者中的预后作用:一项观察性研究

Prognostic role of simple inflammatory biomarkers in patients with severe COVID-19: an observational study.

作者信息

Ntalouka M P, Pantazopoulos I, Brotis A G, Pagonis A, Vatsiou I, Chatzis A, Rarras C N, Kotsi P, Gourgoulianis K I, Arnaoutoglou E M

机构信息

Department of Anesthesiology, Faculty of Medicine, School of Health Sciences, University Hospital of Larissa, University of Thessaly, Larissa, Greece.

Department of Emergency Medicine, Faculty of Medicine, School of Health Sciences, University Hospital of Larissa, University of Thessaly, Larissa, Greece.

出版信息

Hippokratia. 2022 Apr-Jun;26(2):70-77.

PMID:37188050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10177850/
Abstract

BACKGROUND/AIM: Simple inflammatory biomarkers, such as neutrophil to lymphocyte ratio (NLR), could serve as prognosis indicators in patients with Coronavirus disease 2019 (COVID-19). The utility of on-admission inflammatory biomarkers in predicting outcomes was investigated in patients suffering from severe COVID-19 infection.

METHODS

We performed a retrospective study to assess the role of white blood count (WBC), neutrophils (N), lymphocyte (L), platelets (PLTs), C-reactive protein (CRP), reverse transcription polymerase chain reaction (RT-PCR), NLR (N/L), PLR (P/L), dv (derived variation of)-NLR (N/WBC-L), LNR (L/N), dv (derived variation of)-LNR (L/WBC-N), and CLR (CRP/L), in predicting the need for high-flow nasal cannula (HFNC) use, admission to Intensive Care Unit (ICU), and death in adult patients with severe COVID-19 admitted to the Department of Respiratory Medicine from April to September 2021.

RESULTS

One hundred and fifteen patients (60 % males) with a mean age of 57.7 ± 16.3 years were included. Thirty-seven patients (32.2 %) required escalation with HFNC, eight patients (7 %) were admitted to the ICU, and nine patients (7.8%) died. Based on univariate analysis, CRP [odds ratio (OR): 1.25, 95 % confidence interval (CI): 1.1-1.42), LNR (OR: 0.015, 95 % CI: 0.00-0.35), dv-NLR (OR: 510, 95 % CI: 26.7-910), CLR (OR: 710, 95 % CI: 310-210), length of hospitalization (LOH; OR: 1.44, 95 % CI: 1.22-1.63), dyspnea at presentation (OR: 2.83, 95 % CI: 1.23-6.52), and ratio of arterial oxygen partial pressure to fractional inspired oxygen (PaO/FiO) on admission (OR: 0.967, 95 % CI: 0.952-0.983) were independent predictors for oxygen requirements. However, the multivariate analysis showed that LNR (OR: 1.686e0, 95 % CI: 6.441e00-0.441), PaO/FiO on admission (OR: 0.965, 95 % CI: 0.941-0.989), and LOH (OR: 1.717, 95 % CI: 1.274-2.314) were the most important predictor for HFNC use. Nasal congestion at presentation (OR: 11.5, 95 % CI: 1.61-82.8) was a unique and independent predictor for ICU admission. As far as death is concerned, the univariate analysis identified elevated CRP (OR: 1.11, 95 % CI: 1.0-1.24), low RT-PCR (OR: 0.829, 95 % CI: 0.688-0.999), high CLR (OR: 3.210, 95 % CI: 5.8-1.8*10), age (OR: 1.08, 95 % CI: 1.02-1.14), body mass index (BMI) over 30 (OR: 5.25, 95 % CI: 1.26-21.96), the chronic use of angiotensin-converting enzyme inhibitors (OR: 5.72, 95 % CI: 1.35-24.09), nitrates (OR: 14.85, 95 % CI: 1.81-121.8), diuretics (OR: 8.21, 95 % CI: 1.97-34.32), PaO/FiO on admission (OR: 0.983, 95 % CI: 0.970-0.998), and nasal congestion at presentation (OR: 9.81, 95 % CI: 1.40-68.68) as independent predictors. However, the multivariate analysis pinpointed that obesity (BMI >30) (OR: 10.498, 95 % CI: 1.107-99.572) remained the most important predictor for death.

CONCLUSION

LNR and PaO/FiO on admission could be used to timely identify patients requiring HFNC during hospitalization, while obesity (BMI >30) could be an independent predictor of death. Nasal congestion emerges as a unique predictor for ICU admission. HIPPOKRATIA 2022, 26 (2):70-77.

摘要

背景/目的:简单的炎症生物标志物,如中性粒细胞与淋巴细胞比值(NLR),可作为2019冠状病毒病(COVID-19)患者的预后指标。本研究旨在探讨入院时炎症生物标志物对重症COVID-19感染患者预后的预测价值。

方法

我们进行了一项回顾性研究,以评估白细胞计数(WBC)、中性粒细胞(N)、淋巴细胞(L)、血小板(PLTs)、C反应蛋白(CRP)、逆转录聚合酶链反应(RT-PCR)、NLR(N/L)、PLR(P/L)、dv(衍生变异)-NLR(N/WBC-L)、LNR(L/N)、dv(衍生变异)-LNR(L/WBC-N)和CLR(CRP/L)在预测2021年4月至9月入住呼吸内科的成年重症COVID-19患者使用高流量鼻导管(HFNC)、入住重症监护病房(ICU)和死亡方面的作用。

结果

共纳入115例患者(60%为男性),平均年龄57.7±16.3岁。37例患者(32.2%)需要升级使用HFNC,8例患者(7%)入住ICU,9例患者(7.8%)死亡。单因素分析显示,CRP[比值比(OR):1.25,95%置信区间(CI):1.1-1.42]、LNR(OR:0.015,95%CI:0.00-0.